Skip to content

CRSP

CRISPR Therapeutics AG

Stock

$55.43−0.01 (−0.02%)Close Oct 2, 2026

Net income, 2025
−$582M

Net income

Net income by fiscal year

PeriodNet incomeYoY
2025−$582M—
2024−$366M—
2023−$154M—
2022−$650M—
2021$378M—
2020−$349M—
2019$67M—
2018−$165M—
2017−$68M—
2016−$23M—
2015−$26M—
2014−$7.0M—